These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10847650)

  • 1. An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
    Park SJ; Kaye AH; Hill JS
    J Clin Neurosci; 2000 Jan; 7(1):42-7. PubMed ID: 10847650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro].
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R; Uno H; Kodera T
    No To Shinkei; 1995 Oct; 47(10):969-73. PubMed ID: 7577142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor effect of a new anthracycline derivative, MX2, against human glioma cells].
    Kuratsu J; Mihara Y; Kochi M; Takaki S; Ushio Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):399-403. PubMed ID: 2930204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
    Kiya K; Ogasawara H; Fujita H; Sugiyama K; Kurisu K; Kawamoto K; Uozumi T; Shinkai H
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):631-5. PubMed ID: 8470921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of MX2, a new morpholino anthracycline, against experimental brain tumors.
    Izumoto S; Arita N; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Ushio Y
    Anticancer Res; 1990; 10(3):735-9. PubMed ID: 2369088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
    Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
    Watanabe M; Komeshima N; Nakajima S; Tsuruo T
    Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R
    Neurosurgery; 1995 Sep; 37(3):471-6; discussion 476-7. PubMed ID: 7501112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination effect of hyperthermia and MX2 on cultured glioma cell lines].
    Mizumatsu S; Ono Y; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
    Gan To Kagaku Ryoho; 1999 May; 26(6):789-95. PubMed ID: 10410148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Oku Y; Mogami H; Komeshima N
    Gan To Kagaku Ryoho; 1988 May; 15(5):1765-9. PubMed ID: 3369870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in megakaryocytic leukemia cell lines by MX2, a morpholino anthracycline.
    Katsurada T; Adachi M; Kido H; Date M; Kishimoto Y; Yamanaka Y; Kimura T; Fukuhara S
    Exp Hematol; 1997 Sep; 25(10):1077-83. PubMed ID: 9293905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
    Yang JJ; Yin JH; Yang DI
    Neurosci Lett; 2007 May; 418(1):106-10. PubMed ID: 17412510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
    J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
    Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
    Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the morpholino anthracycline 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming units in vitro.
    Ebrahim el-Zayat AA; Izquierdo MA; Clark GM; Von Hoff DD
    Invest New Drugs; 1995; 13(2):125-131. PubMed ID: 8617574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular localization and cellular pharmacokinetics of MX2, a new morpholino anthracycline in glioma cells using confocal laser scanning microscopy.
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Arai Y; Kitai R
    Neurol Res; 1994 Aug; 16(4):257-64. PubMed ID: 7984256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks.
    Horichi N; Tapiero H; Sugimoto Y; Bungo M; Nishiyama M; Fourcade A; Lampidis TJ; Kasahara K; Sasaki Y; Takahashi T
    Cancer Res; 1990 Aug; 50(15):4698-701. PubMed ID: 2164445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of MX2, a new morpholino anthracycline, in CSF following intravenous injection].
    Yamamoto H; Arita N; Ohnishi T; Hiraga S; Izumoto S; Taki T; Higuchi M; Hayakawa T; Shinkai H
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1227-30. PubMed ID: 8333749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment prediction of the chemotherapeutic response of human glioma cell cultures using nuclear magnetic resonance spectroscopy and artificial neural networks.
    El-Deredy W; Ashmore SM; Branston NM; Darling JL; Williams SR; Thomas DG
    Cancer Res; 1997 Oct; 57(19):4196-9. PubMed ID: 9331074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.